ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1663

Walking for Exercise May Be Symptom and Structure Modifying for Those with Established OA and with Varus Alignment – Data from the Osteoarthritis Initiative

Grace Lo1, Surabhi Vinod2, Matthew Harkey3, Timothy McAlindon4, Andrea Kriska5, Bonny Rockette-Wagner5, Charles Eaton6, Marc Hochberg7, Rebecca Jackson8, C. Kent Kwoh9, Michael Nevitt10 and Jeffrey Driban4, 1Michael E. Debakey VA Medical Center, Baylor College of Medicine, Houston, TX, 2Baylor College of Medicine, Houston, 3University of Massachusetts, Worcester, MA, 4Tufts Medical Center, Boston, MA, 5University of Pittsburgh, Pittsburgh, PA, 6Department of Family Medicine and Epidemiology, Warren Alpert Medical School of Brown University,Department of Epidemiology, School of Public Health of Brown University, Providence, RI, 7University of Maryland School of Medicine, Baltimore, MD, 8Ohio State University, Columbus, OH, 9The University of Arizona, Tucson, AZ, 10University of California, San Francisco, San Francisco, CA

Meeting: ACR Convergence 2020

Keywords: exercise, Joint Structure, Osteoarthritis, physical activity

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2020

Title: Osteoarthritis – Clinical Poster II

Session Type: Poster Session D

Session Time: 9:00AM-11:00AM

Background/Purpose: Walking for exercise is recommended for knee osteoarthritis (OA) management though benefits have not been demonstrated in epidemiologic studies. We aimed to assess the relationship between walking for exercise and symptom or structure progression in those with knee OA.

Methods: This was a nested cohort study within the Osteoarthritis Initiative (OAI) of those > 50 years old with radiographic OA (ROA) at baseline. A modified version of the Historical Physical Activity Survey Instrument was used to assess walking for exercise during ages > 50 years old, dichotomously and with 4 levels of walking, including the referent group, those who did not walk for exercise. At baseline and 48-month visits, participants were assessed for frequent knee pain and Kellgren-Lawrence (KL) grade and medial joint space narrowing (JSN) on posterior-anterior semi-flexed knee radiographs. ROA was defined as KL ≥ 2.  Outcomes were: 1) New knee pain – frequent knee pain absent at baseline but present at 48 months (only including those without frequent knee pain at baseline), 2) KL worsening – increase in KL grade, 3)  Medial JSN worsening – increase in medial JSN score, and 4) Improved knee pain – frequent knee pain present at baseline but absent at 48 months  (only including those with frequent knee pain at baseline). Participants with knee arthroplasty between baseline and 48 months were classified as having new knee pain and KL and Medial JSN worsening. Assessed on long limb films, the Hip-Knee-Ankle angles defined static alignment: 1) varus: < -2o, 2) valgus: > +2o, 3) neutral: between -2o and +2o. Including only ROA knees, we performed logistic regression using generalized estimating equations to account for correlation between knees, adjusting for age, sex, and baseline KL grade. Analyses were stratified by static alignment.

Results: Of 1203 participants, 73% walked for exercise. New knee pain was less common in those who walked (OR 0.6; 95%CI 0.4 – 0.8) (see Table). In varus knees, results were similar but also less KL (OR 0.7; 95%CI 0.5 – 1.0) and medial JSN progression (OR 0.7; 95%CI 0.5 – 0.9) was observed (See Table). Neutral and valgus analyses had insufficient numbers to calculate ORs; however in neutral knees, those who walked had more improved knee pain (47% v 39%) but no structural benefits.  In valgus knees, those who walked for exercise had modestly more new knee pain (33% v. 29%), KL progression (20% v. 15%) and medial JSN worsening (9% v. 5%).

Conclusion: Walking may be disease modifying for knee OA. In individuals > 50 years old with knee OA, walking for exercise was associated with less development of frequent knee pain. There may be differential effects of walking based on static alignment.  In varus knees, walking was also associated with less structural progression.  These findings support that walking for exercise should be encouraged for most people with knee OA.  A clinical trial to confirm these findings is warranted.

Table 1. Odds Ratios of outcomes based on walking status; unadjusted and *adjusted for age, sex, and baseline KL grade.


Disclosure: G. Lo, Takeda Pharmaceuticals, 1, Taro Pharmaceuticals, 1, Teva Pharmaceuticals, 1, XBI Biotech Co, 1; S. Vinod, None; M. Harkey, Pfizer, Inc., 1; T. McAlindon, Pfizer, 1, Sanofi Aventis US, 1, Kolon Tissuegene, 1, Samumed, 1, Seikagaku, 1, Kiniksa Pharmaceuticals, 1, Anika Therapeutics, 1; A. Kriska, None; B. Rockette-Wagner, None; C. Eaton, None; M. Hochberg, Bone Therapeutics, 5, Bristol Myers Squibb, 5, Eli Lilly, 5, EMD Serono, 5, Gilead, 5, GlaxoSmithKline, 5, IBSA Institut Biochimique SA, 5, Novartis Pharma AG, 5, Noven Pharmaceuticals Inc., 5, Pfizer Inc., 5, Regenosine, 5, Samumed LLC, 5, Theralogix LLC, 5, Vizuri Health Sciences, 5, ACI Clinical, 5, Covance Inc., 5, Galapagos, 5, ICON plc, 5, IQVIA, 5, Elsevier, 7, Wolters Kluwer, 7, BriOri Biotech, 1, Theralogix LLC., 1, Rheumcon, Inc., 6; R. Jackson, None; C. Kwoh, Thusane, 5, EMD Serono, 5, Express Scripts, 5, Kolon Tissue Gene, 5, Taiwan Liposome, 5, Abbvie, 2, Pfizer, 2, UCB, 2, Novartis, 2, Eli Lilly, 2, GSK, 2; M. Nevitt, None; J. Driban, None.

To cite this abstract in AMA style:

Lo G, Vinod S, Harkey M, McAlindon T, Kriska A, Rockette-Wagner B, Eaton C, Hochberg M, Jackson R, Kwoh C, Nevitt M, Driban J. Walking for Exercise May Be Symptom and Structure Modifying for Those with Established OA and with Varus Alignment – Data from the Osteoarthritis Initiative [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/walking-for-exercise-may-be-symptom-and-structure-modifying-for-those-with-established-oa-and-with-varus-alignment-data-from-the-osteoarthritis-initiative/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/walking-for-exercise-may-be-symptom-and-structure-modifying-for-those-with-established-oa-and-with-varus-alignment-data-from-the-osteoarthritis-initiative/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology